TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Toxicities related to axicabtagene ciloleucel (axi-cel) can be safely and effectively managed, suggest findings from a single-center study.

While evidence suggests that increasing the share of stem cell-like memory T cells (TSCM) in chimeric antigen receptor (CAR) T-cell products might support immunotherapy for solid tumors, a Phase I...

Donor T cells that overexpress the protein BCL2, including those enriched after steroid exposure, protect against graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell...

Researchers have demonstrated the potential for selective irreversible electroporation (sIRE) to improve chimeric antigen receptor (CAR) T-cell function in solid tumors, thus lowering cancer...

Scientists have developed an advanced therapy medicinal product (ATMP) that aims to protect leukemia patients against tumor relapse and potentially fatal infection following haploidentical...

Researchers believe development of chimeric antigen receptor (CAR) T cells targeting the C-X-C chemokine receptor type 4 (CXCR4) could play a role in treating both acute myeloid leukemia (AML) and...